metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology P-70 SEROPREVALENCE OF HEPATITIS C VIRUS IN DONORS OF THE BLOOD BANK OF THE GENE...
Información de la revista
Vol. 24. Núm. S1.
Abstracts of the 2021 Annual meeting of the ALEH (Asociación Latinoamericana para el Estudio del Hígado)
(septiembre 2021)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 24. Núm. S1.
Abstracts of the 2021 Annual meeting of the ALEH (Asociación Latinoamericana para el Estudio del Hígado)
(septiembre 2021)
Open Access
P-70 SEROPREVALENCE OF HEPATITIS C VIRUS IN DONORS OF THE BLOOD BANK OF THE GENERAL HOSPITAL OF MEXICO "DR. EDUARDO LICEAGA " A FOUR-YEAR EVALUATION
Visitas
518
José Luis Pérez Hernández1, María Virginia Murcia Sandoval2, Alejandro Bonilla Ramos2, Carlos Andrés Campoverde Espinoza2, Yadira Lilian Béjar Ramírez3, María de Fátima Higuera de la Tijera4
1 Coordinador de la Clínica de Hígado Servicio de Gastroenterología, Hospital General de México “Dr. Eduardo Liceaga”
2 Residente del servicio de Gastroenterología Hospital General de México “Dr. Eduardo Liceaga”
3 Jefa de Servicio de Banco de Sangre, Hospital General de México “Dr. Eduardo Liceaga”
4 Jefa del Servicio de Gastroenterología Hospital General de México “Dr. Eduardo Liceaga”
Este artículo ha recibido

Under a Creative Commons license
Información del artículo
Suplemento especial
Este artículo forma parte de:
Vol. 24. Núm S1

Abstracts of the 2021 Annual meeting of the ALEH (Asociación Latinoamericana para el Estudio del Hígado)

Más datos
Introduction

Since the molecular identification of the hepatitis C virus (HCV) in 1989 and the development of antibodies as an initial part of the diagnosis of this infection, blood banks have taken an important step to exclude potential donors with this infection, the World Health Organization established as a mandatory measure, the screening of all blood donated for transfusion for communicable infections such as HCV, HBV, HIV and HTLV as a mandatory measure. HCV affects between 130 and 150 million people worldwide, with a global prevalence of around 2.2%, and is the cause of 27% of cirrhosis cases and 25% of primary hepatocellular carcinoma cases in the world. In developed countries.

Objetive

To evaluate the seroprevalence of HCV and risk factors in potential blood donors in a tertiary hospital for 4 years.

Methods

Retrospective, observational, cross-sectional, descriptive study carried out in blood donors at the Hospital General de México "Dr. Eduardo Liceaga." From January 1, 2016, to December 31, 2019. Donor files were reviewed, and those with HCV positivity were analyzed. The SPSS v 22 program was used for statistical analysis.

Results

92,214 donors were included. Of these, 1,265 patients (1.37%), 449 women (35%) and 816 men (64.5%) were positive. Risk factors found in the positive group: alcoholism 153 (12.09%), dental surgery 128 (10.11%). tattoos (6.87%), piercings (7.19%), acupuncture (3.08%) and risky sexual partners (0.23%).

Conclusion

The prevalence of 1.37% is similar to that reported in the literature; the predominance is slightly in the group of men, which contrasts with the past years that due to obstetric events, women were the most prevalent, perhaps it is related to tattoos, piercings, and use of intravenous or intranasal drugs. Although all the donors were approved in the official questionnaire, the positivity may be related to factors not declared by the patients themselves.

El Texto completo está disponible en PDF
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos